ArticleClinical pharmacokinetics2026

Elranatamab Population Pharmacokinetics and Exposure-Response for Cytokine Release Syndrome in Patients with Relapsed or Refractory Multiple Myeloma.

Jennifer E Hibma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.